Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED)

Clinical trial NCT03921424 · COMPLETED

Trial details

NCT number: NCT03921424
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2019-11-05
Primary completion: 2021-05-03
Enrollment: 407

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.